Revelation Biosciences Warrant (REVBW) EPS by Year
REVBWNASDAQ
Revelation Biosciences, Inc. Warrant lost $23.95 per diluted share in fiscal year 2025. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Revelation Biosciences, Inc. Warrant has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
More Revelation Biosciences, Inc. Warrant financials
Revelation Biosciences, Inc. Warrant lost $23.95 per diluted share in fiscal year 2025.
Revelation Biosciences, Inc. Warrant (REVBW) reported -$5.92 in diluted earnings per share in Q3 2026.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Revelation Biosciences, Inc. Warrant (REVBW) reported on that line in every period on record.
